Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Oshadi D - Oshadi Drug Administration

Next Previous
X
Search
Drug Profile

Oshadi D - Oshadi Drug Administration

Alternative Names: DNase in Oshadi carrier

Latest Information Update: 04 May 2018

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Oshadi Drug Administration
  • Class Antineoplastics
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Basal cell cancer; Non-small cell lung cancer
  • No development reported Solid tumours; Systemic lupus erythematosus

Most Recent Events

  • 16 Apr 2018 Oshadi Drug Administration suspends patient enrolment in a phase I/IIa trial for Mesothelioma (Combination therapy) in Israel (NCT01627795)
  • 16 Apr 2018 Oshadi Drug Administration suspends patient enrolment in a phase II trial for Acute myeloid leukaemia andPrecursor cell lymphoblastic leukaemia lymphoma(Second-line therapy or greater, Combination therapy) in Israel (PO) (NCT02462265)
  • 16 Jul 2016 No recent reports of development identified for phase-I development in Solid-tumours(Combination therapy, Metastatic disease) in Israel (PO, Controlled release)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top